Navid Sadri

Navid Sadri, MD, PhD is an Associate Professor in the Department of Pathology at Case Western Reserve University School of Medicine. He serves as Division Chief of Genomic and Molecular Pathology and Medical Director of the University Hospitals Translational Laboratory. His expertise lies in molecular diagnostics, precision oncology, and genomic medicine. Dr. Sadri leads initiatives in liquid biopsy applications, antimicrobial resistance profiling, and implementation of machine learning in pathology workflows.

Education: MD and PhD from New York University School of Medicine (2010/2008), BS from Haverford College (2001). Training includes residency and fellowships at the Hospital of the University of Pennsylvania and Memorial Sloan-Kettering Cancer Center. His research focuses on molecular characterization of hematologic malignancies, gastrointestinal cancers, and infectious diseases. Key contributions include optimizing Helicobacter pylori resistance testing and evaluating cost-effectiveness of precision medicine programs.

Research emphasizes translational applications of next-generation sequencing and genomic profiling in clinical decision-making. He has led studies on clonal cytopenia progression, SARS-CoV-2 molecular diagnostics, and genomic correlates of cancer therapy response. Dr. Sadri chairs multidisciplinary tumor boards and collaborates across academic and community healthcare systems to advance personalized medicine practices.